Development of patient-derived xenograft (PDX) models for small cell lung cancer (SCLC) as a preclinical platform for drug development

被引：0
|
作者：
Mullins, Chelsea [1 ]
Ricono, Jill [1 ]
Nair, Praveen [1 ]
Mirsaidi, Cyrus [1 ]
Broudy, Thomas [1 ]
机构：
[1] Mol Response, San Diego, CA USA
来源：
CANCER RESEARCH | 2015年 / 75卷
关键词：
D O I：
10.1158/1538-7445.AM2015-4209
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4209
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Establishment of patient-derived xenograft (PDX) models for small cell lung cancer (SCLC) as a preclinical platform for drug development
    Carlson, Patrick
    Ricono, Jill
    Mullins, Chelsea
    Broudy, Thomas
    Mirsaidi, Cyrus
    Nair, Praveen
    CANCER RESEARCH, 2014, 74 (19)
  • [2] Development of patient-derived xenograft (PDX) models for pancreatic carcinoma as a preclinical platform for drug development
    Ricono, Jill
    Thatte, Jayant
    Scott, Colleen
    Broudy, Thomas B.
    CANCER RESEARCH, 2016, 76
  • [3] Patient-derived Xenograft Models of Small Cell Lung Cancer for Therapeutic Development
    Vidhyasagar, V.
    Ul Haq, S.
    Lok, B. H.
    CLINICAL ONCOLOGY, 2020, 32 (10) : 619 - 625
  • [4] Dose optimization of olaparib plus temozolomide in small cell lung cancer (SCLC) patient-derived xenograft (PDX) models for clinical translation
    Drapkin, Benjamin J.
    Phat, Sarah
    Myers, David T.
    Zhong, Jun
    Yeap, Beow Y.
    Leo, Elisabetta
    Stansiszewska, Anna
    Smith, Aaron
    Cadogan, Elaine
    Pietanza, Maria C.
    Dyson, Nicholas J.
    Farago, Anna
    CANCER RESEARCH, 2019, 79 (13)
  • [5] Establishment of patient-derived xenografts (PDX) models for small cell lung (SCL) as a pre-clinical platform for drug development
    Broudy, T.
    Ricono, J.
    Mullins, C.
    Mirsaidi, C.
    Nair, P.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : 59 - 59
  • [6] Development of breast cancer patient-derived xenograft models as preclinical tool for drug discovery
    Rymer, Isha C.
    Wang, Jinwei
    Zhu, Zhou
    Schwab, Richard
    Wallace, Anne M.
    Blair, Sarah L.
    Greenberg, Norman
    Yang, Wei J.
    CANCER RESEARCH, 2011, 71
  • [7] Patient-Derived Xenograft Models(PDX) of Lung Squamous Cell Carcinoma(SCC) for Preclinical Studies
    Kim, T. H.
    Lee, J.
    Park, B.
    Kim, H. K.
    Lee, J.
    Hwang, E.
    Lee, H.
    Koo, K.
    Lee, H.
    Lee, S.
    Rhee, H.
    Lee, J. E.
    Choi, Y.
    Kim, J.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S987 - S988
  • [8] Development of patient-derived xenograft (PDX) models for gastrointestinal stromal tumors (GIST) as a pre-clinical platform for drug development
    Ricono, Jill
    Mullins, Chelsea
    Nair, Praveen
    Mirsaidi, Cyrus
    Broudy, Thomas
    CANCER RESEARCH, 2015, 75
  • [9] Breaking barriers: patient-derived xenograft (PDX) models in lung cancer drug development-are we close to the finish line?
    Karim, Nagla Abdel
    Zaza, Mohamed
    Subramanian, Janakiraman
    TRANSLATIONAL LUNG CANCER RESEARCH, 2024, 13 (08) : 2098 - 2102
  • [10] The Use of Patient-Derived Xenograft (PDX) Models to Predict Patient Response in Non-Small Cell Lung Cancer (NSCLC)
    Isler, J.
    Katz, A.
    Sorogin, A.
    Scoppetuolo, M.
    Nechushtan, H.
    Pass, H.
    Davies, A.
    Paz, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S42 - S43
12345